Who is stressed? A pilot study of salivary cortisol and alpha-amylase concentrations in agoraphobic patients and their novice therapists undergoing in vivo exposure

Psychoneuroendocrinology

Volumn 49, Issue 1, 2014, Pages 280-289

  Schumacher, Sarah ^a,b   Gaudlitz, Katharina ^a   Plag, Jens ^a   Miller, Robert ^c   Kirschbaum, Clemens ^c   Fehm, Lydia ^b   Fydrich, Thomas ^b   Ströhle, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Agoraphobia; Exposure therapy; Salivary alpha amylase; Salivary cortisol; Stress; Therapist trainees

Indexed keywords

AMYLASE; HYDROCORTISONE; ALPHA AMYLASE SALIVA ISOENZYME; BIOLOGICAL MARKER;

ADULT; AGORAPHOBIA; ANXIETY; ANXIETY ASSESSMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; MALE; PARAMEDICAL PERSONNEL; PERCEIVED STRESS; PHYSIOLOGICAL STRESS; PILOT STUDY; SALIVA ANALYSIS; SALIVA LEVEL; STRESS; STRESS ASSESMENT; VISUAL ANALOG SCALE; BEHAVIOR THERAPY; CLINICAL TRIAL; COMPLICATION; ENZYMOLOGY; MENTAL STRESS; METABOLISM; PERCEPTION; PHYSIOLOGY; PSYCHOTHERAPY; SALIVA; YOUNG ADULT;

ADULT; AGORAPHOBIA; ANXIETY; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYDROCORTISONE; IMPLOSIVE THERAPY; MALE; PERCEPTION; PILOT PROJECTS; PSYCHOTHERAPY; SALIVA; SALIVARY ALPHA-AMYLASES; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84922445861     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.07.016     Document Type: Article

References (46)

1. Alpers G.W., Abelson J.L., Wilhelm F.H., Roth W.T. Salivary cortisol response during exposure treatment in driving phobics. Psychosom. Med. 2003, 65:679-687.
2. Bandelow B., Wedekind D., Pauls J., Broocks A., Hajak G., Ruther E. Salivary cortisol in panic attacks. Am. J. Psychiat. 2000, 157:454-456.
3. Bentz D., Michael T., de Quervain D.J.F., Wilhelm F.H. Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications. J. Anxiety Disord. 2010, 24:223-230.
4. Bosch J.A., Veerman E.C.I., de Geus E.J., Proctor G.B. α-Amylase as a reliable and convenient measure of sympathetic activity: don't start salivating just yet!. Psychoneuroendocrino 2011, 36:449-453.
5. Bouton M.E., Mineka S., Barlow D.H. A modern learning theory perspective on the etiology of panic disorder. Psychol. Rev. 2001, 108:4-32.
6. Cameron O.G., Lee M.A., Curtis G.C., McCann D.S. Endocrine and physiological changes during "spontaneous" panic attacks. Psychoneuroendocrinology 1987, 12:321-331.
7. Chrousos G.P. Stress and disorders of the stress system. Nat. Rev. Endocrinol. 2009, 5:374-381.
8. Deacon B.J., Farrell N.R., Kemp J.J., Dixon L.J., Sy J.T., Zhang A.R., McGrath P.B. Assessing therapist reservations about exposure therapy for anxiety disorders: the Therapist Beliefs about Exposure Scale. J. Anxiety Disord. 2013, 27:772-780.
9. Delgado M.R., Olsson A., Phelps E.A. Extending animal models of fear conditioning to humans. Biol. Psychol. 2006, 73:39-48.
10. Duchesne A., Pruessner J.C. Association between subjective and cortisol stress response depends on the menstrual cycle phase. Psychoneuroendocrinology 2013, 38:3155-3159.
11. Engert V., Plessow F., Miller R., Kirschbaum C., Singer T. Cortisol increase in empathic stress is modulated by emotional closeness and observation modality. Psychoneuroendocrinology 2014, 45:192-201.
12. Foley P., Kirschbaum C. Human hypothalamus-pituitary-adrenal axis responses to acute psychosocial stress in laboratory settings. Neurosci. Biobehav. Rev. 2010, 35:91-96.
13. Fredrikson M., Sundin O., Frankenhaeuser M. Cortisol excretion during the defense reaction in humans. Psychosom. Med. 1985, 47:313-319.
14. Freiheit S.R., Vye C., Swan R., Cady M. Cognitive-behavioral therapy for anxiety: is dissemination working?. Behav. Ther. 2004, 27:25-32.
15. Gloster A.T., Wittchen H.-U., Einsle F., Lang T., Helbig-Lang S., Fydrich T., Fehm L., Hamm A.O., Richter J., Alpers G.W., Gerlach A.L., Ströhle A., Kircher T., Deckert J., Zwanzger P., Höfler M., Arolt V. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT. J. Consult. Clin. Psych. 2011, 79:406-420.
16. Goisman R.M., Warshaw M.G., Keller M.B. Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996. Am. J. Psychiat. 1999, 156:1819-1821.
17. Hahlweg K., Fiegenbaum W., Frank M., Schroeder B., von Witzleben I. Short- and long-term effectiveness of an empirically supported treatment for agoraphobia. J. Consult. Clin. Psychol. 2001, 69:375-382.
18. Hamacher-Dang T., Engler H., Schedlowski M., Wolf O.T. Stress enhances the consolidation of extinction memory in a predictive learning task. Front. Behav. Neurosci. 2013, 7. 10.3389/fnbeh.2013.00108.
19. Harned M.S., Dimeff L.A., Woodcock E.A., Skutch J.M. Overcoming barriers to disseminating exposure therapies for anxiety disorders: a pilot randomized controlled trial of training methods. J. Anxiety Disord. 2011, 25:155-163.
20. Hipol L.J., Deacon B.J. Dissemination of evidence-based practices for anxiety disorders in Wyoming: a survey of practicing psychotherapists. Behav. Modif. 2013, 37:170-188.
21. Jansson L., Öst L.-G. Behavioral treatments for agoraphobia: an evaluative review. Clin. Psychol. Rev. 1982, 2:311-336.
22. Kirschbaum C., Hellhammer D.H. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology 1994, 19:313-333.
23. Kirschbaum C., Kudielka B.M., Gaab J., Schommer N.C., Hellhammer D.H. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosom. Med. 1999, 61:154-162.
24. Kudielka B.M., Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol. Psychol. 2005, 69:113-132.
25. Lundberg U., Frankenhaeuser M. Pituitary-adrenal and sympathetic-adrenal correlates of distress and effort. J. Psychosom. Res. 1980, 24:125-130.
26. Marcks B.A., Weisberg R.B., Keller M.B. Psychiatric treatment received by primary care patients with panic disorder with and without agoraphobia. Psychiatr. Serv. 2009, 60:823-830.
27. McGaugh J.L., Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Curr. Opin. Neurobiol. 2002, 12:205-210.
28. Miller G.D., Iverson K.M., Kemmelmeier M., Maclane C., Pistorello J., Fruzzetti A.E., Crenshaw K.Y., Erikson K.M., Katrichak B.M., Oser M., Pruitt L.D., Watkins M.M. A pilot study of psychotherapist trainees' alpha-amylase and cortisol levels during treatment of recently suicidal clients with borderline traits. Prof. Psychol.-Res. Pr. 2010, 41:228-235.
29. Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J. Affect. Disord. 2005, 88:27-45.
30. Nater U.M., Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology 2009, 34:486-496.
31. Nesse R.M., Curtis G.C., Thyer B.A., McCann D.S., Huber-Smith M.J., Knopf R.F. Endocrine and cardiovascular responses during phobic anxiety. Psychosom. Med. 1985, 47:320-332.
32. Olatunji B.O., Deacon B.J., Abramowitz J.S. The cruelest cure? Ethical issues in the implementation of exposure-based treatments. Cogn. Behav. Pract. 2009, 16:172-180.
33. Petrowski K., Herold U., Joraschky P., Wittchen H.U., Kirschbaum C. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses. Psychoneuroendocrinology 2010, 35:414-421.
34. Powers M.B., Deacon B.J. Dissemination of empirically supported treatments for anxiety disorders: Introduction to the special issue. J. Anxiety Disord. 2013, 27:743-744.
35. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931.
36. Rohleder N., Nater U.M. Determinants of salivary alpha-amylase in humans and methodological considerations. Psychoneuroendocrinology 2009, 34:469-485.
37. Rohleder N., Wolf J.M., Maldonado E.F., Kirschbaum C. The psychosocial stress-induced increase in salivary alpha-amylase is independent of saliva flow rate. Psychophysiology 2006, 43:645-652.
38. Roth C., Siegl J., Aufdermauer N., Reinecker H. Therapie von Angst- und Zwangspatienten in der verhaltenstherapeutischen Praxis. Verhaltenstherapie 2004, 14:16-21.
39. Sanchez-Meca J., Rosa-Alcazar A.I., Marin-Martinez F., Gomez-Conesa A. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin. Psychol. Rev. 2010, 30:37-50.
40. Schumacher S., Kirschbaum C., Fydrich T., Ströhle A. Is salivary alpha-amylase an indicator of autonomic nervous system dysregulations in mental disorders?-a review of preliminary findings and the interactions with cortisol. Psychoneuroendocrino 2013, 38:729-743.
41. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiat. 1998, 59(Suppl 20):22-33.
42. Siegmund A., Koster L., Meves A.M., Plag J., Stoy M., Strohle A. Stress hormones during flooding therapy and their relationship to therapy outcome in patients with panic disorder and agoraphobia. J. Psychiat. Res. 2011, 45:339-346.
43. Ströhle A., Kellner M., Holsboer F., Wiedemann K. Atrial natriuretic hormone decreases endocrine response to a combined dexamethasone-corticotropin-releasing hormone test. Biol. Psychiat. 1998, 43:371-375.
44. Thoma M.V., Kirschbaum C., Wolf J.M., Rohleder N. Acute stress responses in salivary alpha-amylase predict increases of plasma norepinephrine. Biol. Psychol. 2012, 91:342-348.
45. van Duinen M., Schruers K., Griez E. Desynchrony of fear in phobic exposure. J. Psychopharmacol. 2010, 24:695-699.
46. Weckesser L.J., Plessow F., Pilhatsch M., Muehlhan M., Kirschbaum C., Miller R. Do venepuncture procedures induce cortisol responses? A review, study, and synthesis for stress research. Psychoneuroendocrinology 2014, 46:88-99.